Muthusamy Shanmugam, HEAD OF R&D, COO-NOVITIUM Operations at ANI PHARMACEUTICALS INC (ANIP), sold 29,438 shares at $51.48 ($1.5M) on 2023-07-19, disclosed to the SEC on 2023-07-21.
Scheduled sale ($1.5M) by HEAD OF R&D, COO-NOVITIUM Operations under a pre-arranged 10b5-1 plan. Pre-set trade — not a discretionary signal on the stock.
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $51.48 | 5,969 | $307K | 20.1% |
| 2 | $51.48 | 5,969 | $307K | 20.1% |
| 3 | $51.52 | 6,000 | $309K | 20.2% |
| 4 | $52.56 | 11,500 | $604K | 39.6% |
| Total | $51.91 avg | 29,438 | $1.5M | 100% |
| Filing → |
| ANIP | SELL | 2025-05-13 | $54K | — | Filing → |
| ANIP | SELL | 2024-07-19 | $170K | — | Filing → |
| ANIP | SELL | 2024-07-17 | $3.9M | — | Filing → |